Why the study?
Does peak systolic tricuspid annular velocity assessed by Doppler tissue imaging predict survival and event-free survival in patients with symptomatic heart failure?
Does peak systolic tricuspid annular velocity assessed by Doppler tissue imaging predict survival and event-free survival in patients with symptomatic heart failure?
Peak systolic tricuspid annular velocity (Sa) assessed by Doppler tissue imaging is a significant independent predictor of survival and event-free survival in patients with symptomatic heart failure.
No takes yet. Share an insight, caveat, or question.
Sa may aid risk stratification in symptomatic HF; leaves open whether it should guide therapy pending prospective validation.
Jaroslav Meluzı́n (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: